Model NO.: APIA2
Purity: 99% Min
Appearance: White Crystalline Powder
Product Name: Elvitegravir
CAS NO.: 697761-98-1
Quality Standard: USP32/BP2007/EP7
Elvitegravir (EVG; JTK-303; GS-9137) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively. Elvitegravir is a human immunodeficiency virus integrase inhibitor with EC50 of 0.7, 2.8 and 1.4 for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD.
Elvitegravir (also known as GS-9137 or JTK-303), a monoketo acid modified from the distinct diketo acid moiety (DKA) motif, is a potent inhibitor of human immunodeficiency virus type I (HIV-1) integrase, an enzyme integrating the viral DNA into the cellular DNA of the host during HIV replication. Elvitegravir inhibits the function of HIV-1 integrase through blocking viral DNA strand transfer and integration, which prevents the replication of HIV and subsequently allows viral DNA to be metabolized by cellular enzymes. Multiple studies indicate that elvitegravir not only inhibits the replication of a variety of subtypes of HIV-1 but also exhibits antiviral activity against murine leukemia virus (MLV) and simian immunodeficirncy virus (SIV).
Used to Anti-AIDS
|Appearance:||white,Crystalline Powder or colorless crystal|
|Loss on Drying:||≤0.2%|
|Residue on ignition:||≤0.1%|
|Acidity or Alkalinity:||Conform|
|Readily Carbonizable Substances:||Conform|